The largest database of trusted experimental protocols

6 protocols using mmp 12

1

Synthetic Protocols for Enzyme Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reactants and reagents were purchased from either Sigma-Aldrich, Alfa-Aesar, or Combi-blocks and used with no additional purification. Synthetic protocols and details for 137 are reported in the SI. Absorbance assays were performed using a BioTek Synergy HT microplate reader. Fluorescence assays were performed using either a BioTek Synergy HT microplate reader or a BioTek Synergy H4 microplate reader. hCAII was prepared as previously reported,[30 ] MMP-12 was purchased from Enzo Life Sciences (Farmingdale, NY, USA), NDM-1 was supplied as a gift from Dr. David Tierney (U. Miami, Ohio), and influenza endonuclease was expressed and purified as previously reported.[31 (link)]
+ Open protocol
+ Expand
2

Fluorogenic MMP-12 Inhibitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MMP-12 and OmniMMP fluorogenic substrate were purchased as an assay kit from Enzo Life Sciences, and the assay was performed in a Costar black 96-well plate. Each well contained a total volume of 100 μL including buffer (50 mM HEPES, 10 mM CaCl2, 0.05% Brij-35, pH 7.5), human recombinant MMP-12 (0.7 U per well, Enzo Life Sciences), inhibitor (200 μM), and fluorogenic OmniMMP substrate (4 μM MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2-AcOH, Enzo Life Sciences). The enzyme and inhibitor were initially incubated together for 15 min at 37 °C, after which the reaction was initiated by substrate addition. The change in fluorescence was monitored for 20 min with excitation at 320 nm and reading emission at 400 nm. The negative control wells contained no inhibitor and were arbitrarily set as 100% enzyme activity.
+ Open protocol
+ Expand
3

Fluorogenic Assay for MMP-2 and MMP-12 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
MMP-2 and −12, and OmniMMP fluorogenic substrate were purchased from Enzo Life Sciences (Farmingdale, NY, USA). The assays were carried out in black 96-well plates (Corning). Each well contained a volume of 100 μL including buffer (50 mM HEPES, 10 mM CaCl2, 0.05% Brij-35, pH 7.5), human recombinant MMP (1.16 U/well of MMP-2, 0.007 U/well of MMP-12, Enzo Life Sciences), inhibitor (various concentrations, 1mM – 5 μM), and fluorogenic OmniMMP substrate (4 μM Mca-Pro-LeuGly-Leu-Dpa-Ala-Arg-NH2•AcOH, Enzo Life Sciences). The enzyme and inhibitor were incubated in solution at 37 °C for 30 min, followed by the addition of the substrate to initiate the reaction. The change in fluorescence was monitored over 20 min with excitation and emission wavelengths at 320 and 400 nm, respectively. The negative control wells, containing no inhibitor, were arbitrarily set as 100% activity. The positive control wells, containing 200 μM NSA, were arbitrarily set as 0% activity. MMP activity was defined as the ratio of fluorescence increase in the inhibitor wells relative to the negative control wells, expressed as a percentage. The assays were performed in triplicate.
+ Open protocol
+ Expand
4

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed on ice for 10 min in 20 mM Tris-HCl (pH 7.4), 50 mM NaCl, 50 mM sodium pyrophosphate, 30 mM NaF, 5 μM zinc chloride, 2 mM iodoacetic acid, and 1% Triton X-100. The lysates were centrifuged at 15,000 × g for 15 min at 4°C, and protein concentrations were measured using the bicinchoninic acid (BCA) method (Pierce, Rockford, IL, USA). Proteins were separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. Membranes were blocked in TBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl) containing 5% nonfat dry milk for 1 h and incubated with primary antibodies to NF-κB phospho-p65 (Cell Signaling, Danvers, MA, USA), NF-κB p65 (Santa Cruz, Dallas, TX, USA), phospho-IκB-α (Cell Signaling), IκB-α (Cell Signaling), MMP-12 (Enzo Life Sciences, Farmingdale, NY, USA), MMP-13 (Enzo Life Sciences), or β-actin (Cell Signaling, Danvers, MA, USA) for 16 h at 4°C. The immunoblots were washed and incubated with appropriate secondary antibodies and visualized using SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL, USA).
+ Open protocol
+ Expand
5

Screening Enzymatic Activities and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents and acetazolamide,[16 (link)] were obtained from Sigma-Aldrich. 1,2-HOPO-2,[25 (link)] CGS[12 (link)] and SAHA[26 ] were prepared by literature methods. Absorbance assays were performed using a BioTek Synergy HT microplatereader. Fluorescence assays were performed using either a BioTek FLx800 microplate reader or a BioTek Synergy HT microplate reader. MMP-2, MMP-12, HDAC-1, HDAC-6 and metallothionein were obtained from Enzo Life Sciences (Farmingdale, NY). Human carbonic anhydrase, myoglobin and transferrin were obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
6

Neutrophil Isolation and Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils were isolated from the femur and tibia of mice as previously described [12 (link)]. Using a 26-gauge needle and 10 ml syringe filled with RPMI 1640 media supplemented with 1% penicillin/streptomycin and 2 mM EDTA, bone marrow cells were flushed from the bones. The cell suspension was filtered through 30 μm filter to obtain single cell suspension. Single cell suspension was incubated with anti-Ly6G magnetic ultrapure microbeads (Miltenyi Biotec, #130–120–337), and neutrophils were sorted through magnetic columns in the AutoMACS Pro Separator. Purity of Ly6g+ neutrophils using this approach has previously been shown to be >95% by both flow cytometry and immunofluorescence [9 (link)]. Neutrophils (1 × 106) were stimulated with IL-1β (200 ng/ml, RnD systems, #401-ML), IL-4 (20 ng/ml, RnD systems, #404-ML), or MMP-12 (500 ng/ml, Enzo Life Sciences #BML-SE138–0010) and incubated for 15 min at 37 °C in 1 ml of RPMI 1640 media. The negative control was unstimulated cells. Samples sizes were n = 3 M and 3 F biological replicates for each stimulus group, performed as a four-group paired stimulation. Following stimulation, cells were centrifuged at 800 xg for 8 min and cell pellets were used for the transcription factor signaling array, while the secretome was used for the cytokine array.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!